← Back
$OTLK All transactions

Outlook Therapeutics, Inc.

A

$ Value

$0

Shares

286,734

Price

$0

Filed

Oct 3

Insider

Name

Huang Andong

Title

CIK

0001815678

Roles

Director

Transaction Details

Transaction Date

2025-10-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

286,734

Footnotes

This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "2024 Plan") and shall fully vest on October 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control. | The options were granted under the 2024 Plan in lieu of $50,000 cash fees payable under the Issuer's Non-Employee Director Compensation Policy and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.

Filing Info

Accession No.

0001649989-25-000010

Form Type

4

Issuer CIK

0001649989

Huang Andong's History

Date Ticker Type Value
2025-10-03 OTLK A $0
2025-10-01 OTLK A $0

Other Insiders at OTLK (90d)

No other insider activity at this issuer in the last 90 days.